NEW ROLES FOR FC RECEPTORS IN NEURODEGENERATION-THE IMPACT ON IMMUNOTHERAPY FOR ALZHEIMER’S DISEASE
There are an estimated 18 million Alzheimer’s disease (AD) sufferers worldwide and with no disease modifying treatment currently available, development of new therapies represents an enormous unmet clinical need. AD is characterised by episodic memory loss followed by severe cognitive decline and is...
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
Frontiers Media S.A.
2014-08-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Acceso en liña: | http://journal.frontiersin.org/Journal/10.3389/fnins.2014.00235/full |